Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cancer Vaccines | 4 | 2020 | 136 | 2.07 | Why? |
| Precision Medicine | 3 | 2018 | 1477 | 1.02 | Why? |
| Esophagogastric Junction | 1 | 2018 | 30 | 0.74 | Why? |
| Th1 Cells | 2 | 2021 | 1228 | 0.68 | Why? |
| Esophageal Neoplasms | 1 | 2018 | 357 | 0.50 | Why? |
| RNA | 2 | 2017 | 1278 | 0.49 | Why? |
| Stomach Neoplasms | 1 | 2018 | 477 | 0.48 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2018 | 830 | 0.43 | Why? |
| Immunotherapy | 3 | 2020 | 2421 | 0.41 | Why? |
| T-Lymphocytes | 4 | 2021 | 6670 | 0.37 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.31 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.24 | Why? |
| Antibodies, Neutralizing | 7 | 2021 | 25288 | 0.23 | Why? |
| Antibodies, Monoclonal | 2 | 2018 | 8041 | 0.23 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.23 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.20 | Why? |
| Antigens, Neoplasm | 2 | 2020 | 230 | 0.20 | Why? |
| Interleukin-2 | 1 | 2021 | 443 | 0.19 | Why? |
| Latvia | 1 | 2018 | 50 | 0.19 | Why? |
| Maximum Tolerated Dose | 1 | 2018 | 65 | 0.19 | Why? |
| Histidine | 1 | 2018 | 72 | 0.18 | Why? |
| Hepatitis B Core Antigens | 1 | 2018 | 76 | 0.18 | Why? |
| beta 2-Microglobulin | 1 | 2017 | 102 | 0.17 | Why? |
| CD8 Antigens | 1 | 2017 | 72 | 0.17 | Why? |
| Neoplasms | 4 | 2020 | 17251 | 0.17 | Why? |
| Drug Dosage Calculations | 1 | 2018 | 243 | 0.16 | Why? |
| Gene Transfer Techniques | 1 | 2017 | 134 | 0.16 | Why? |
| Epitopes | 2 | 2020 | 4113 | 0.15 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.15 | Why? |
| Antibodies, Bispecific | 1 | 2017 | 207 | 0.14 | Why? |
| Vaccinia virus | 1 | 2017 | 346 | 0.14 | Why? |
| Oligopeptides | 1 | 2018 | 576 | 0.13 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.13 | Why? |
| Vaccines, Synthetic | 3 | 2021 | 3231 | 0.13 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.13 | Why? |
| Germany | 2 | 2020 | 9196 | 0.13 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2021 | 5837 | 0.13 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.13 | Why? |
| Immunodominant Epitopes | 1 | 2018 | 813 | 0.12 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.12 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.11 | Why? |
| Genetic Vectors | 1 | 2017 | 1600 | 0.10 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.10 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.10 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.10 | Why? |
| Virion | 1 | 2018 | 1444 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 6 | 2021 | 37182 | 0.10 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.09 | Why? |
| Injections, Intramuscular | 2 | 2021 | 800 | 0.09 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.09 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.09 | Why? |
| Immune Evasion | 1 | 2017 | 2081 | 0.08 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.08 | Why? |
| Single-Blind Method | 2 | 2020 | 1283 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Mice, Inbred BALB C | 3 | 2021 | 5814 | 0.06 | Why? |
| Female | 12 | 2021 | 380317 | 0.06 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.06 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.06 | Why? |
| Male | 11 | 2021 | 367725 | 0.06 | Why? |
| Humans | 16 | 2021 | 930598 | 0.06 | Why? |
| Adult | 8 | 2021 | 244371 | 0.05 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.05 | Why? |
| Solubility | 1 | 2021 | 382 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.05 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.04 | Why? |
| Mice, Inbred NOD | 1 | 2017 | 134 | 0.04 | Why? |
| Immunoblotting | 1 | 2017 | 180 | 0.04 | Why? |
| eIF-2 Kinase | 1 | 2017 | 117 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.04 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Protein Multimerization | 1 | 2021 | 1336 | 0.04 | Why? |
| Mice | 3 | 2021 | 21357 | 0.03 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.03 | Why? |
| Stress, Physiological | 1 | 2018 | 378 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2017 | 1027 | 0.03 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.03 | Why? |
| Pain | 1 | 2021 | 1084 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2020 | 1649 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Luminescent Measurements | 1 | 2017 | 924 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Headache | 1 | 2020 | 2257 | 0.03 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.02 | Why? |
| Internationality | 1 | 2021 | 3297 | 0.02 | Why? |
| Animals | 3 | 2021 | 78931 | 0.02 | Why? |
| Aging | 1 | 2021 | 3581 | 0.02 | Why? |
| China | 2 | 2021 | 50654 | 0.02 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
Türeci's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(109)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(182)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_